Grifols

Grifols is a global healthcare company that has enhanced the health and well-being of people around the world since its founding in 1909. Our commitment to innovation and quality has made us a leader in essential plasma-derived medicines, which are crucial for the treatment of patients with chronic, rare, and life-threatening diseases. We operate in over 110 countries, continually expanding our reach to serve and innovate for patients.

At Grifols, we understand that our customers face numerous health challenges, which is why we prioritize patient needs in everything we do. Our state-of-the-art facilities enable us to develop and produce safe and effective therapies derived from human plasma. We have built the largest network of donation centers globally, ensuring the rigorous collection of plasma needed for our products. With over 23,000 employees dedicated to this mission, we are proud to create jobs and drive sustainability in the regions we serve. Our extensive research and development efforts amount to a significant investment aimed at fostering breakthroughs in various therapeutic areas, including immunology, hepatology, and neurology.